Variant report
Variant | esv989880 |
---|---|
Chromosome Location | chr11:5758238-5765079 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr11:5757074..5759023-chr11:5763300..5765136,2 | K562 | blood: |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000181023 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs372206500 | chr11:5758245-5758246 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs149260229 | chr11:5758256-5758257 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs62617826 | chr11:5758270-5758271 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
4 | rs199587977 | chr11:5758280-5758281 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs202000107 | chr11:5758294-5758295 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs375273446 | chr11:5758323-5758324 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs191729390 | chr11:5758347-5758348 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs545857409 | chr11:5758370-5758371 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs565167175 | chr11:5758379-5758380 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs148531293 | chr11:5758382-5758383 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs62621167 | chr11:5758386-5758387 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
12 | rs36073866 | chr11:5758394-5758395 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs112188360 | chr11:5758395-5758396 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs142329473 | chr11:5758397-5758398 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs114002556 | chr11:5758408-5758409 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs369551291 | chr11:5758444-5758445 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs35783800 | chr11:5758447-5758448 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs548303084 | chr11:5758477-5758478 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs200213218 | chr11:5758486-5758487 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs144847345 | chr11:5758490-5758491 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs374174730 | chr11:5758495-5758496 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs146750076 | chr11:5758508-5758509 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs370914437 | chr11:5758518-5758519 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs530934947 | chr11:5758529-5758530 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs552686611 | chr11:5758568-5758569 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs369203795 | chr11:5758574-5758575 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs140442383 | chr11:5758604-5758605 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs145233768 | chr11:5758608-5758609 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs376119189 | chr11:5758609-5758610 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs137956225 | chr11:5758623-5758624 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs371399429 | chr11:5758632-5758633 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs199693302 | chr11:5758641-5758642 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs568273124 | chr11:5758644-5758645 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs4486660 | chr11:5758646-5758647 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
35 | rs145949953 | chr11:5758650-5758651 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs377695102 | chr11:5758654-5758655 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs148131819 | chr11:5758698-5758699 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs371017819 | chr11:5758714-5758715 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs116421977 | chr11:5758715-5758716 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs201011587 | chr11:5758737-5758738 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs75720413 | chr11:5758814-5758815 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs7928052 | chr11:5758833-5758834 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
43 | rs550993032 | chr11:5758835-5758836 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs564505585 | chr11:5758885-5758886 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs192417754 | chr11:5758944-5758945 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs185692757 | chr11:5758965-5758966 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs190203963 | chr11:5759015-5759016 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs7938793 | chr11:5759016-5759017 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs542486043 | chr11:5759043-5759044 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs563564078 | chr11:5759064-5759065 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Neuroblastoma | 18923191 | CNVD |
Breast cancer | 19432969 | CNVD |
Alzheimer''s disease | 17576883 | CNVD |
Long-qt syndrome | 17576883 | CNVD |
Emphysema | 19352772 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Chordoma | 18071362 | CNVD |
Breast cancer | 16608533 | CNVD |
Cancer | 21183584 | CNVD |
Gastric adenocarcinoma | 19115996 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Burkitt''s lymphoma | 19759907 | CNVD |
Breast cancer | 17603634 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Melanoma | 18172304 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Wilms tumour | 21544195 | CNVD |
Parathyroid adenoma | 22454399 | CNVD |
Chordoma | 21602918 | CNVD |
Breast cancer | 21949216 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 19222835 | CNVD |
T-cell acute lymphoblastic leukemia | 20065082 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Beckwith-Wiedemann syndrome | 21518781 | CNVD |
Wilms tumour | 21518781 | CNVD |
Hepatoblastoma | 21518781 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Gastrointestinal stromal cancer | 17535989 | CNVD |
Paraganglioma | 17535989 | CNVD |
Pulmonary chondroma | 17535989 | CNVD |
Gastric cancer | 17908304 | CNVD |
Barrett''s syndrome | 19417022 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Multiple myeloma | 20724749 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Lung cancer | 18438408 | CNVD |
Autism | 22495311 | CNVD |
Esophageal adenocarcinoma | 18519675 | CNVD |
Ovine squamous-cell carcinoma | 17599052 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Glioma | 17123091 | CNVD |
Lung cancer | 16773561 | CNVD |
Neuroblastoma | 21124317 | CNVD |
Lung adenocarcinoma | 17086460 | CNVD |
Lung cancer | 17086460 | CNVD |
Schizophrenia | 21399695 | CNVD |
Gastric cancer | 16891809 | CNVD |
Cancer | 17160897 | CNVD |
Multiple myeloma | 16616336 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Breast cancer | 21364760 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Breast cancer | 22522925 | CNVD |
Pancreatic cancer | 23613489 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
Non-syndromic sensorineural hearing loss | 18451855 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
early-passage human iPS cells | 21368824 | CNVD |
Non-syndromic sensorineural hearing loss | 21293372 | CNVD |
Non-syndromic sensorineural hearing loss | 19587683 | CNVD |
Ollier disease | 21235737 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr11:5747400-5762400 | Weak transcription | Left Ventricle | heart |
2 | chr11:5756800-5760400 | Weak transcription | Ovary | ovary |
3 | chr11:5757400-5759800 | Enhancers | Bone Marrow Derived Cultured Mesenchymal Stem Cells | Bone marrow |
4 | chr11:5757600-5760200 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
5 | chr11:5757800-5758400 | Enhancers | Foreskin Keratinocyte Primary Cells skin02 | Skin |
6 | chr11:5757800-5758400 | Enhancers | NHEK | skin |
7 | chr11:5757800-5758600 | Enhancers | Muscle Satellite Cultured Cells | -- |
8 | chr11:5757800-5758800 | Enhancers | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
9 | chr11:5757800-5759600 | Enhancers | NHDF-Ad | bronchial |
10 | chr11:5757800-5759600 | Enhancers | Osteobl | bone |
11 | chr11:5757800-5759800 | Enhancers | HSMMtube | muscle |
12 | chr11:5757800-5760200 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
13 | chr11:5758000-5759200 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
14 | chr11:5758400-5759600 | Enhancers | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
15 | chr11:5758400-5759600 | Enhancers | HSMM | muscle |
16 | chr11:5759000-5759400 | Enhancers | NH-A | brain |
17 | chr11:5759400-5759800 | Enhancers | hESC Derived CD56+ Ectoderm Cultured Cells | ES cell derived |
18 | chr11:5761800-5762000 | ZNF genes & repeats | Gastric | stomach |
19 | chr11:5762600-5762800 | Bivalent Enhancer | H9 Derived Neuron Cultured Cells | ES cell derived |